Dr. June Robinson is Research Professor of Dermatology at Northwestern University Feinberg School of Medicine. Her research focuses on primary (sun protection) and secondary (early detection) of melanoma and non-melanoma skin cancer in at-risk populations. During three decades serving as the PI, co-I, and consultant to funded projects, the research performed by our team resulted in numerous publications in peer–reviewed journals, book chapters and text books as well as service on national and international consensus panels addressing skin cancer prevention and early detection. Dr. Robinson mentors medical students, research fellows, residents and junior faculty. She was honored to receive the American Cancer Society National Service Award, St. George Medal, in 2004, and the Gold Medal of the American Academy of Dermatology in 2015.
Questions & Answers
This could be adapted for other high risk patients such as those who are immunosuppressed due to HIV infection, taking immunosuppressive medications, or taking medicines that make their skin sensitive to the sun. A list of medications is provided below:
-Tetracyclines (especially doxycycline)
-Phenothiazines (eg, chlorpromazine)
-St. John's wort
But when also using the workbook that accompanies the program in tailoring to a different patient population, one would need to remove the references to kidney transplant patients throughout the workbook, (e.g. the cover page, pages 3, 4, 5 , 6, etc.) to change on which would not be difficult to do.